News Pfizer leukaemia drug accepted by NICE Bosulif is first drug to be funded following reassessment.
Clinical Sandoz biosimilar trial hailed as 'landmark' Patients switched between the originator and the near-copy.
News Medivation in merger talks with Sanofi and others Sources say Pfizer and Celgene are also interested.
News BIND accepts Pfizer bid following bankruptcy Bid of $20 million may be enough to acquire all of BIND's assets.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
